|
| |
|
Sify.com » Topics » Glenn Saldanha
Glenn Saldanha News
Glenmark close to final clinical trials for asthma, arthritis drugs Glenmark Pharmaceuticals is set to enter the final stage of clinical trials for its new drug, Revamilast, across several countries this year. It is meant for treatment of inflammatory disorders like asthma and rheumatoid arthritis. Glenmark may soon seek approval for Phase-III trials in the US, UK and India. “Glenmark plans to file an IND (Investigational New Drug application) for Revamilast
Glenmark's different route to US drug market
At a time when most Indian drug makers are launching generics to monetise patent expiries in the US, Glenmark has chosen to walk a road less travelled. The company has chosen a strategy to capture
BS People: Sandeep Gupta
For India’s leading pharmaceutical firm Glenmark, the appointment of Sandeep Gupta as its new chief operating officer is more of a vision statement.
Biotech ind seeks clarity on regulatory framework
The opportunity of India becoming a global research hub for the pharmaceutical sector will be lost if the regulatory issues and policy ambiguities are not rectified, and thereby would fail to |
|
|
© Copyright Sify Technologies Ltd, 1998-2011. All rights reserved. India News Portal, Sify.com hosted at SifyHosting India's first Level 3 Internet Data Centre. Site optimized for Internet Explorer 5.5 and above. See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise | |
